Publication | Closed Access
Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study
250
Citations
0
References
2018
Year
Egfr T790mSclerostinBone Morphogenic ProteinMedicinePathologyPharmacotherapyAura3 StudyPharmacologyResistance Mechanisms
No additional data available for this publication yet. Check back later!